Fred Alger Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,603
Closed -$207K 563
2018
Q2
$207K Buy
+1,603
New +$207K ﹤0.01% 385